Cranberry Juice Shows Potential to Boost Antibiotic Effectiveness and Reduce Resistance in Laboratory Studies

Recent laboratory research conducted by scientists at the Institut National de la Recherche Scientifique in Montreal, Canada, has revealed that certain, yet unidentified, compounds present in cranberry juice may enhance the efficacy of antibiotics and help prevent the development of bacterial resistance.

During the study, researchers cultivated 32 strains of human-derived Escherichia coli (E. coli) and treated them with the antibiotic fosfomycin (FOS) alongside juice from the North American cranberry (Vaccinium macrocarpon L.). The results demonstrated that the addition of cranberry juice inhibited the emergence of resistance in 72% of the tested bacterial strains and simultaneously increased the antibacterial activity of FOS.

Fosfomycin is known for its bactericidal properties, which stem from its ability to irreversibly disrupt the synthesis of murein, an essential component of the bacterial cell wall, ultimately leading to loss of cell wall stability. The antibiotic enters bacterial cells through two main transport systems: the glycerol-3-phosphate transporter (GlpT) and the hexose phosphate uptake transporter (UhpT).

The experiments indicated that exposure to cranberry juice suppressed the expression of the GlpT transporter in E. coli. This action effectively blocked a critical pathway used by the bacteria to develop resistance and manage its energy metabolism. Importantly, the UhpT transporter remained unaffected, allowing fosfomycin to continue entering the bacterial cells. As a result, the laboratory findings suggested an increase in antibiotic uptake and a reduction in the formation of resistance among the treated bacteria.

While these results offer promising insights into the potential use of cranberry juice as an adjunct to antibiotic therapy, the authors emphasize that the findings are currently limited to in vitro laboratory conditions. They note that the observed effects cannot yet be extrapolated to living organisms or clinical situations without further research. Additional studies are required to determine whether the laboratory results are reproducible in physiological models and to identify the specific cranberry compounds responsible for the observed effects. Furthermore, it remains to be investigated if similar interactions can be achieved with other antibiotics beyond fosfomycin.

This research provides a foundation for future investigations into natural substances that may help address the growing challenge of antibiotic resistance. As resistance to antibiotics remains a significant global health concern, exploring alternative strategies to enhance antibiotic efficacy is a critical area of focus for the scientific and medical communities.

The full study has been published in the journal Applied and Environmental Microbiology.